UNSPSC 51422511: Triclonide

This classification denotes a topical corticosteroid with the molecular formula C24H28CL3FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PSM3RT117Z. European Medicines Agency schedules triclonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11276MIG. The term TRICLONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, no. 10 1974, list 14. ).

UNSPSC 51422511 Triclonide is a Commodity code showing minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities tagged to this code—a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs—do not represent triclonide procurement. Naloxone is an opioid antagonist used in overdose response; the Texas RFI addresses pharmacy benefit management and manufacturer contracting models. Neither opportunity involves triclonide, a corticosteroid medication. The code appears to have been misapplied or carries minimal purchasing volume under state and local jurisdiction, as recent solicitation activity does not reflect the product category the code nominally represents.

No substantive market signal supports active pursuit under this code. The mismatch between the code's nominal scope and the recent opportunities posted against it suggests either sporadic, locally isolated demand or systematic miscoding in state and local procurement systems. Business development professionals should verify directly with issuing bodies whether triclonide procurement is anticipated and confirm correct UNSPSC coding before investing resources in pursuit.